15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
23
The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives.
Smithkline Beecham Pharmaceuticals
37
Design and syntheses of 1,6-naphthalene derivatives as selective HCMV protease inhibitors.
Wyeth Research
53
Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.
Glaxosmithkline
19
Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability.
Glaxosmithkline
43
Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality.
Glaxosmithkline
12
Inhibition of human cytomegalovirus protease by enedione derivatives of thieno[2,3-d]oxazinones through a novel dual acylation/alkylation mechanism.
Smithkline Beecham Pharmaceuticals
34
Inhibition of herpes proteases and antiviral activity of 2-substituted thieno[2,3-d]oxazinones.
Smithkline Beecham Pharmaceuticals
20
Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease.
Smithkline Beecham Pharmaceuticals
18
Inhibition of human cytomegalovirus protease N(o) with monocyclic beta-lactams.
Boehringer Ingelheim (Canada)
19
Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease.
Glaxo Wellcome Research and Development
